Corporate
CleanSpace Technology - Joint lead manager to IPO
Fri 23rd October, 2020

Wilsons Advisory was pleased to act as Joint Lead Manager to CleanSpace Holdings Limited $131.4 million Initial Public Offering (IPO). Shares in the company were issued at $4.41 per share and the first day of trading saw shares close up 68% at $7.42 per share. The IPO positions the business to capitalise on its leading technology and market opportunity, and is the next step in providing financial flexibility and enabling the company to execute on its growth strategy.

Head of Corporate Finance Rob Snow said, “Wilsons Advisory are pleased to have been able to support another great business with its listing on the ASX. CleanSpace demonstrates that there is strong investor interest in innovative healthcare technology opportunities.”

Founded in Australia in 2009 by a team of biomedical engineers, CleanSpace manufactures respiratory protection equipment for workers in the healthcare and industrial sectors. Throughout the COVID-19 pandemic, CleanSpace reported a fourfold increase in demand for its respirators, and the company continues to grow with international approvals and established domestic and offshore teams supporting sales of a product portfolio to large healthcare and industrial RPE markets. 80% of masks produced by CleanSpace go overseas. Chief executive Alex Birrell said, the battery-powered masks are 10 times more effective at filtering particles than standard N95 masks used in many hospitals.

CleanSpace’s success is due in large part to their innovative technology which incorporates miniaturisation (size and weight), smart pressure driven algorithms, intuitive function and unique neck mounted design, to achieve the highest level of protection. In the last 10 years they have continued to invest in research and development programs resulting in differentiated design and approved products that provide compelling employer and user benefits, namely higher protection with improved compliance and productivity.

Wilsons Advisory is looking forward to assisting CleanSpace in the next phase of its journey as a listed company.

For more information contact:

Head of Corporate Finance, Rob Snow

rob.snow@wilsonsadvisory.com.au / (02) 8247 6645

Head of Corporate Finance Origination, Richard Sherman

richard.sherman@wilsonsadvisory.com.au / (03) 9640 3879

About Wilsons: Wilsons is a financial advisory firm focused on delivering strategic and investment advice for people with ambition – whether they be a private investor, corporate, fund manager or global institution. Its client-first, whole of firm approach allows Wilsons to partner with clients for the long-term and provide the wide range of financial and advisory services they may require throughout their financial future. Wilsons is staff-owned and has offices across Australia.

Disclaimer: This communication has been prepared by Wilsons Advisory and Stockbroking Limited (ACN 010 529 665; AFSL 238375) and/or Wilsons Corporate Finance Limited (ACN 057 547 323; AFSL 238383) (collectively “Wilsons”). It is being supplied to you solely for your information and no action should be taken on the basis of or in reliance on this communication. To the extent that any information prepared by Wilsons contains a financial product advice, it is general advice only and has been prepared by Wilsons without reference to your objectives, financial situation or needs. You should consider the appropriateness of the advice in light of your own objectives, financial situation and needs before following or relying on the advice. You should also obtain a copy of, and consider, any relevant disclosure document before making any decision to acquire or dispose of a financial product. Wilsons’ Financial Services Guide is available at wilsonsadvisory.com.au/disclosures.

All investments carry risk. Different investment strategies can carry different levels of risk, depending on the assets that make up that strategy. The value of investments and the level of returns will vary. Future returns may differ from past returns and past performance is not a reliable guide to future performance. On that basis, any advice should not be relied on to make any investment decisions without first consulting with your financial adviser. If you do not currently have an adviser, please contact us and we would be happy to connect you with a Wilsons representative.

To the extent that any specific documents or products are referred to, please also ensure that you obtain the relevant disclosure documents such as Product Disclosure Statement(s), Prospectus(es) and Investment Program(s) before considering any related investments.

Wilsons and their associates may have received and may continue to receive fees from any company or companies referred to in this communication (the “Companies”) in relation to corporate advisory, underwriting or other professional investment services. Please see relevant Wilsons’ disclosures at www.wilsonsadvisory.com.au/disclosures.

  • Share This Article

Written by

Staff Writer

Related articles